Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies France

Research

Date range: 1 July 2021 - 30 June 2022

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies published between 1 July 2021 - 30 June 2022 which are tracked by the Nature Index.

Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Article Count and Share for Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies
Count Share
1 0.03

Outputs by subject (Share)

Outputs by subject
Subject Count Share
1 0.03

Share output for the past 5 years

Share per year
2017 2018 2019 2020 2021
0.08 1.05 0.00 0.36 0.15

Compare Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies with other institutions

Collaboration

Date range: 1 July 2021 - 30 June 2022

International vs. domestic collaboration by Share

  • 33.39% Domestic
  • 66.61% International

Hover over the graph to view the percentage of collaboration.


Top 10 domestic collaborators with Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies by Share (25 total)

  1. Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies and Assistance Publique-Hôpitaux de Paris (AP-HP) (0.05)
    Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies0.03
    Assistance Publique-Hôpitaux de Paris (AP-HP)0.03
  2. Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies and Institute of Cardiometabolism and Nutrition (ICAN) (0.04)
    Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies0.03
    Institute of Cardiometabolism and Nutrition (ICAN)0.01
  3. Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies and National Institute for Health and Medical Research (INSERM) (0.04)
    Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies0.03
    National Institute for Health and Medical Research (INSERM)0.01
  4. Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies and University of Paris-Saclay (0.04)
    Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies0.03
    University of Paris-Saclay0.01
  5. Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies and Marie Lannelongue Hospital (0.04)
    Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies0.03
    Marie Lannelongue Hospital0.01
  6. Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies and Sorbonne University (0.03)
    Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies0.03
    Sorbonne University0.00
  7. Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies and Institut d'Optique Graduate School (IOGS) (0.03)
    Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies0.03
    Institut d'Optique Graduate School (IOGS)0.00
  8. Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies and Superior National School of Advanced Techniques (ENSTA ParisTech) (0.03)
    Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies0.03
    Superior National School of Advanced Techniques (ENSTA ParisTech)0.00
  9. Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies and National Research Institute for Agriculture, Food and Environment (INRAE) (0.03)
    Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies0.03
    National Research Institute for Agriculture, Food and Environment (INRAE)0.00
  10. Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies and National Office for Aerospace Studies and Research (ONERA) (0.03)
    Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies0.03
    National Office for Aerospace Studies and Research (ONERA)0.00

Top 10 international collaborators with Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies by Share (22 total)

  1. Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies and Imperial College London (ICL) (0.16)
    Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies0.03
    Imperial College London (ICL)0.13
  2. Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies and University of Cambridge (0.15)
    Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies0.03
    University of Cambridge0.12
  3. Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies and The University of Sheffield (0.15)
    Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies0.03
    The University of Sheffield0.12
  4. Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies and Royal United Hospitals Bath NHS Trust (0.10)
    Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies0.03
    Royal United Hospitals Bath NHS Trust0.07
  5. Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies and Great Ormond Street Hospital for Children NHS Trust (0.09)
    Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies0.03
    Great Ormond Street Hospital for Children NHS Trust0.06
  6. Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies and VU Amsterdam (0.08)
    Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies0.03
    VU Amsterdam0.05
  7. Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies and Guy's and St Thomas' NHS Foundation Trust (0.08)
    Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies0.03
    Guy's and St Thomas' NHS Foundation Trust0.05
  8. Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies and Royal Free London NHS Foundation Trust (0.08)
    Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies0.03
    Royal Free London NHS Foundation Trust0.05
  9. Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies and Sheffield Teaching Hospitals NHS Foundation Trust (0.08)
    Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies0.03
    Sheffield Teaching Hospitals NHS Foundation Trust0.05
  10. Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies and Imperial College Healthcare NHS Trust (0.06)
    Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies0.03
    Imperial College Healthcare NHS Trust0.03

Relationships

Partner Institutions

Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies is a research collaboration whose article contributions are accrued to its participating partner institutions below.